Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and Coronary Restenosis

angiotensin ii has been researched along with Coronary Restenosis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (69.23)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Hu, X; Jiang, H; Lu, Z; Xu, C; Zhang, J; Zhou, X1
Choi, E; Ham, O; Han, SM; Hwang, KC; Lee, C; Lee, J; Lee, S; Lee, SY; Lim, S; Park, JH; Seo, HH; Seung, M; Yun, I1
Arbonés, ML; Campanero, MR; Esteban, V; García-Redondo, AB; Jiménez-Borreguero, LJ; Méndez-Barbero, N; Novensá, L; Redondo, JM; Roqué, M; Salaices, M; Vila, L1
Chen, SY; Shi, N; Wang, JN1
Wilensky, RL1
Dohi, Y; Goto, T; Hayashi, K; Ikeda, K; Nakazawa, A; Sato, K; Sugiyama, M; Takase, H; Toriyama, T; Ueda, R1
Takai, S1
Chen, G; Li, T; Liu, N; Su, J; Tang, C; Tang, J; Wang, X; Wu, X; Yao, X; Zhang, Y1
Iwasaka, T; Okigaki, M1
Sada, M1
Estes, A; Malik, KU; Parmentier, JH; Schaefer, S; Zhang, C1
Buikema, H; de Smet, BJ; Groenewegen, HC; Roks, AJ; van der Harst, P; van Gilst, WH; Zijlstra, F1
Chen, G; Liu, N; Wang, X1

Reviews

3 review(s) available for angiotensin ii and Coronary Restenosis

ArticleYear
Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?
    Cardiovascular drugs and therapy, 2003, Volume: 17, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Restenosis; Humans; Receptors, Angiotensin; Stents; Tetrazoles; Valine; Valsartan

2003
[Role of chymase in vascular diseases and the efficacy of chymase inhibitor].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Blood Pressure; Chymases; Coronary Restenosis; Drug Design; Graft Occlusion, Vascular; Humans; Mast Cells; Serine Endopeptidases; Serine Proteinase Inhibitors; Vascular Diseases

2003
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1

2004

Other Studies

10 other study(ies) available for angiotensin ii and Coronary Restenosis

ArticleYear
Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
    Biological & pharmaceutical bulletin, 2013, Volume: 36, Issue:10

    Topics: Angiotensin II; Animals; Antioxidants; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Citrus; Coronary Restenosis; Dinoprost; Flavanones; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor RelA; Tunica Intima

2013
Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth muscle cell.
    Journal of cellular biochemistry, 2015, Volume: 116, Issue:4

    Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Dynamins; Hydrogen Peroxide; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phosphorylation; Protein Kinase C-delta; Rats

2015
Regulator of calcineurin 1 mediates pathological vascular wall remodeling.
    The Journal of experimental medicine, 2011, Sep-26, Volume: 208, Issue:10

    Topics: Aneurysm; Angiotensin II; Animals; Aorta; Calcineurin; Calcium-Binding Proteins; Cell Movement; Coronary Restenosis; Cyclosporine; Gene Expression Regulation; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Smooth, Vascular; NFATC Transcription Factors; Rats; Rats, Wistar; Signal Transduction

2011
Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells.
    Free radical biology & medicine, 2012, Jan-01, Volume: 52, Issue:1

    Topics: Adenoviridae; Angiotensin II; Animals; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cell Movement; Cell Proliferation; Coronary Restenosis; Gene Transfer Techniques; Male; Mitochondria; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Superoxide Dismutase; Superoxides

2012
Increased endogenous endothelin-1 in coronary circulation is associated with restenosis after coronary angioplasty.
    The Canadian journal of cardiology, 2003, Volume: 19, Issue:8

    Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin II; Biomarkers; Coronary Angiography; Coronary Circulation; Coronary Restenosis; Endothelin-1; Female; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Norepinephrine; Risk Factors; Serotonin; Statistics as Topic; Vascular Patency

2003
Effects of certain vasoactive peptides on pathogenesis of vascular restenosis.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2003, Volume: 18, Issue:1

    Topics: Adrenomedullin; Angioplasty, Balloon; Angiotensin II; Animals; Aorta, Thoracic; Calcitonin Gene-Related Peptide; Cell Division; Cells, Cultured; Coronary Restenosis; Endothelin-1; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Vasodilator Agents

2003
[Prevention of cardiovascular events in the era of drug eluting stents (DES) and angiotension II receptor blockers (ARB)].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Artery Disease; Coronary Restenosis; Stents

2005
Essential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injury.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:4

    Topics: Angiotensin II; Animals; Carotid Arteries; Catheterization; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Fibrosis; Gene Expression Regulation, Enzymologic; Inflammation; Male; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tunica Intima

2006
Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation.
    International journal of cardiology, 2008, May-23, Volume: 126, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Coronary Restenosis; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stents; Tunica Intima

2008
[Effects of vasoactive peptides on the development of restenosis].
    Zhonghua yi xue za zhi, 2001, Feb-10, Volume: 81, Issue:3

    Topics: Adrenomedullin; Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Cell Division; Coronary Restenosis; Endothelins; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Peptides; Rats; Tunica Intima

2001